Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metamizole effect on CYP2B6 activity by genotype in healthy volunteers
ChiCTR-TNRC-10001118Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Metamizole sodium and bupropion (3 cohorts), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoints: Bupropion AUC0-infinity and Bupropion AUC0-48. Started Jan 2008; status: completed.
02
Drugs
Metamizole sodiumbupropion
Beyond the preview
Go deeper on ChiCTR-TNRC-10001118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-10001118.